Clinical trial
Prospective Validation and Clinical Evaluation of a New Posaconazole Dosing Regimen for Children and Adolescents With Cystic Fibrosis and Aspergillus Infection
NCT04966234 is registered in ClinicalTrials.gov with Bambino Gesù Hospital and Research Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Validation and Clinical Evaluation of a New Posaconazole Dosing Regimen for Children and Adolescents With Cystic Fibrosis and Aspergillus Infection
- Lead sponsor
- Bambino Gesù Hospital and Research Institute
- Phase
- Phase 2/3
- Overall status
- Unknown status
- Start date
- April 22, 2021
- Completion date
- November 30, 2023
- Enrollment
- 135 (estimated)
- Sites
- 31
Conditions
As the registry lists them; a condition with its own page is linked.